Related Experiment Video
Updated: May 21, 2026

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
TRC8 suppresses tumorigenesis through targeting heme oxygenase-1 for ubiquitination and degradation
1Institute of Pharmacology, School of Medicine, National Yang-Ming University, Taipei, Taiwan, ROC.
Abstract:
The TRC8 gene, which was previously shown to be disrupted by a 3;8 chromosomal translocation in hereditary kidney cancer, encodes for an endoplasmic reticulum-resident E3 ligase. Studies have shown that TRC8 exhibits a tumor-suppressive effect through its E3-ligase activity. Therefore, the identification of its physiological substrates will provide important insights into the molecular mechanism underlying TRC8-mediated tumor suppression. Here we show that TRC8 targets heme oxygenase-1 (HO-1), an antioxidant enzyme highly expressed in various cancers, for ubiquitination and degradation. Ectopic TRC8 expression suppresses HO-1-induced cancer cell growth and migration/invasion. Conversely, HO-1 depletion reduced the tumorigenic and invasive capacities promoted by TRC8 knockdown. HO-1 downregulation in renal carcinoma cells induces a mitotic delay at G2/M phase by increasing the intracellular reactive oxygen species and the DNA-damage-induced checkpoint activation. These results highlight the tumorigenic role of HO-1 and the importance of TRC8-mediated HO-1 degradation in the control of cancer growth.
Insights
The TRC8 gene degrades the HO-1 enzyme, suppressing kidney cancer growth. TRC8-mediated HO-1 degradation is crucial for controlling cancer progression and tumor suppression.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The TRC8 gene, encoding an endoplasmic reticulum-resident E3 ligase, is implicated in hereditary kidney cancer.
- TRC8 demonstrates tumor-suppressive effects via its E3-ligase activity.
- Identifying TRC8's substrates is key to understanding its tumor suppression mechanisms.
Purpose of the Study:
- To identify physiological substrates of TRC8.
- To elucidate the molecular mechanisms of TRC8-mediated tumor suppression.
- To investigate the role of TRC8 and its substrate HO-1 in cancer.
Main Methods:
- Investigated TRC8's interaction with heme oxygenase-1 (HO-1).
- Assessed the effects of TRC8 expression and HO-1 depletion on cancer cell growth, migration, and invasion.
- Analyzed HO-1 downregulation-induced effects on cell cycle, reactive oxygen species, and DNA damage checkpoints.
Main Results:
- TRC8 targets heme oxygenase-1 (HO-1) for ubiquitination and degradation.
- Ectopic TRC8 expression inhibits HO-1-driven cancer cell proliferation and metastasis.
- HO-1 depletion counteracts the pro-tumorigenic effects of TRC8 knockdown.
- HO-1 downregulation in renal carcinoma cells causes G2/M mitotic delay via increased ROS and DNA damage checkpoint activation.
Conclusions:
- HO-1 plays a tumorigenic role in cancer.
- TRC8-mediated degradation of HO-1 is essential for tumor suppression.
- This pathway is critical for controlling cancer cell growth, migration, and invasion.
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
TGF - β Signaling Pathway